| Ytd | -89.26% | |
| 1y | -98.61% |
| Open | 1.56 | Prev Close | 1.50 | Low | 1.42 | High | 1.56 | Mkt Cap | 3.28M |
| Vol | 46.00K | Avg Vol | 3.01M | EPS | 570.50 | P/E | 0.00 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.99 | 200-d Avg | 14.35 | 1yr Est | 0.00 |
Friedman Industries Inc (NASDAQ: FRD) rose in pre-market trading after posting strong Q4 earnings. O
US stocks rise with Nasdaq up 150 points. Dow up 0.54%, Nasdaq up 0.63%, S&P 500 up 0.26%. Indus
US stocks up, Dow gains 250 pts. Dow up 0.58% while NASDAQ up 0.67%. Materials shares jump 1.5%, com
Propanc Biopharma, Inc. (NASDAQ:PPCB) ("Propanc" or the "Company"), a biopharmaceuti
The Company plans to file a Clinical Trial Application (CTA) in Australia for a Phase 1b, First-In-H
Based in Europe, the CDMO provides end-to-end services for preclinical and clinical projects, with e
Propanc Biopharma (NASDAQ:PPCB) reported quarterly losses of $(0.28) per share. This is a 97.76 perc
Stocks That Hit 52-Week Highs On Tuesday